Literature DB >> 5904191

Adrenergic activation by anticholinesterases.

V Varagić, M Krstić.   

Abstract

Mesh:

Substances:

Year:  1966        PMID: 5904191

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  8 in total

1.  The effect of physostigmine and Neostigmine on the concentration of glycogen in the liver of the rat.

Authors:  V M Varagić; M Terzić; B B Mrsulja
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967-09-15

2.  Effect of Paraoxon and antidotes on lipolysis of isolated fat cells.

Authors:  H D Peters; P Selhorst; V Dinnendahl; K U Helm; P S Schöndhöfer
Journal:  Arch Toxikol       Date:  1973

3.  Studies on the role of central catecholaminergic mechanisms in the antidotal effect of the oxime HI 6 in soman poisoned mice.

Authors:  C Reithmann; H Arbogast; M Hallek; G Auburger; L Szinicz
Journal:  Arch Toxicol       Date:  1988-08       Impact factor: 5.153

4.  Central effects of paraoxon on haemodynamics in the cat.

Authors:  J H de Neef; A J Porsius
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

5.  Pharmacological analysis of a cholinergic receptor mediated regulation of brain norepinephrine neurons.

Authors:  G Engberg; T H Svensson
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

6.  The effects of physostigmine on the oxygen uptake in rat brain tissue.

Authors:  D S Andjelković; M R Terzić
Journal:  Experientia       Date:  1979-03-15

7.  Oxotremorine-induced hypertension in the anaesthetized rat.

Authors:  J L Walker; D F Weetman
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739

8.  The effect of enkephalins and of beta-endorphin on the hypertensive response to physostigmine in the rat.

Authors:  V M Varagić; V Stojanović
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.